(Q40411184)

20 September 2017

1 reference

title

Ventricular tachyarrhythmias, myocardial ischemia, and sudden cardiac death in patients with hypertensive heart disease (English)

1 reference

20 September 2017

1 reference

Zehender M

1

1 reference

20 September 2017

Faber T

2

1 reference

20 September 2017

Koscheck U

3

1 reference

20 September 2017

Meinertz T

4

1 reference

20 September 2017

Just H

5

1 reference

20 September 2017

publication date

1 July 1995

1 reference

20 September 2017

1 reference

20 September 2017

volume

18

1 reference

20 September 2017

issue

7

1 reference

20 September 2017

page(s)

377-383

1 reference

Relation of Left Ventricular Mass and Geometry to Morbidity and Mortality in Uncomplicated Essential Hypertension

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

Noninvasive evaluation of ventricular hypertrophy in professional athletes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

Impaired left ventricular functional reserve in hypertensive patients with left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

Precursors of sudden coronary death. Factors related to the incidence of sudden death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

Increased size of myocardial infarction in dogs with chronic hypertension and left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

Circadian variation in the frequency of sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

Circadian variation in the frequency of onset of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

Circadian rhythms in coronary heart disease. Their pathophysiology and significance for myocardial ischemia, acute myocardial infarct and sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

Aggravation of arrhythmia: a complication of antiarrhythmic drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

Significance of myocardial alpha- and beta-adrenoceptors in catecholamine-induced cardiac hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

Incidence of sudden cardiac death associated with coronary artery occlusion in dogs with hypertension and left ventricular hypertrophy is reduced by chronic beta-adrenergic blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

Acceleration of the wavefront of myocardial necrosis by chronic hypertension and left ventricular hypertrophy in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

Time course of regression of left ventricular hypertrophy in hypertensive patients treated with atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

Coronary morbidity and mortality, pre-existing silent coronary artery disease, and mild hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Prevalence and natural history of electrocardiographic left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Unrecognized myocardial infarction and hypertension: the Framingham Study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Sudden death: lessons from subsets in population studies

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Voltage criteria of left ventricular hypertrophy in sudden and nonsudden coronary artery disease mortality: the Italian section of the Seven Countries Study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Clinical significance of ventricular arrhythmias in patients with and without coronary artery disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Symmetric cardiac enlargement in highly trained endurance athletes: a two-dimensional echocardiographic study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Rapid ventricular filling in left ventricular hypertrophy: I. Physiologic hypertrophy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Echocardiographic evaluation of long-term effects of exercise on left ventricular hypertrophy and function in professional bicyclists

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Rapid ventricular filling in left ventricular hypertrophy: II. Pathologic hypertrophy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Systemic hypertension, left ventricular hypertrophy and coronary artery disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Usefulness of echocardiographic left ventricular hypertrophy, ventricular tachycardia and complex ventricular arrhythmias in predicting ventricular fibrillation or sudden cardiac death in elderly patients

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Left ventricular hypertrophy is associated with worse survival independent of ventricular function and number of coronary arteries severely narrowed

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Usefulness of echocardiographic left ventricular hypertrophy and silent ischemia in predicting new cardiac events in elderly patients with systemic hypertension or coronary artery disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Hypertension and sudden death. Increased ventricular ectopic activity in left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Determinants of ventricular ectopy in hypertensive cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Ventricular arrhythmia in untreated newly presenting hypertensive patients compared with matched normal population

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Baseline rest electrocardiographic abnormalities, antihypertensive treatment, and mortality in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Arrhythmogenic potential of diuretic induced hypokalaemia in patients with mild hypertension and ischaemic heart disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Systemic hypertension, diuretic drugs, arrhythmias and death

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Prevalence of circadian variations and spontaneous variability of cardiac disorders and ECG changes suggestive of myocardial ischemia in systemic arterial hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Hemodynamic, humoral and volume findings in systemic hypertension with isolated ventricular septal hypertrophy.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Asymptomatic ventricular arrhythmias and mortility risk in subjects withs with left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Incidence and clinical relevance of QT prolongation caused by the new selective serotonin antagonist ketanserin

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Effects of hypertrophy on the coronary circulation

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Mechanisms of ventricular arrhythmias in cardiac failure and hypertrophy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Analysis of myocardial action potential in left ventricular hypertrophy of Goldblatt rats

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Membrane potentials and contractile events of hypertrophied rat cardia muscle

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Chronic hypertension and left ventricular hypertrophy facilitate induction of sustained ventricular tachycardia in dogs 3 hours after left circumflex coronary artery occlusion

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Tolerance of the hypertrophic heart to ischemia. Studies in compensated and failing dog hearts with pressure overload hypertrophy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Acute changes in blood pressure as a cause of cardiac arrhythmias

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

[Circadian incidence of cardiovascular incidents and hypertension upon awakening]

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Impact of left ventricular hypertrophy on ventricular arrhythmias in the absence of coronary artery disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Disorders of coronary microcirculation and arrhythmias in systemic arterial hypertension.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Left ventricular hypertrophy sensitizes the myocardium to the development of ischaemia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Hypertensive heart disease: relationship of silent ischemia to coronary artery disease and left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Usefulness of simultaneous ambulatory electrocardiographic and blood pressure monitoring in detecting myocardial ischemia in patients > 70 years of age with systemic hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Reversal of left ventricular hypertrophy in hypertensive patients treated with methyldopa. Lack of association with blood pressure control

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180705

7 January 2021

Identifiers

DOI

10.1002/CLC.4960180705

1 reference

20 September 2017

1 reference